Kyoko Mori, Osamu Hiraoka, Masanori Ikeda, Yasuo Ariumi, Akiko Hiramoto, Yusuke Wataya, Nobuyuki Kato – 26 March 2013 – Ribavirin (RBV) is often used in conjunction with interferon‐based therapy for patients with chronic hepatitis C.
Carlos Benítez, María‐Carlota Londoño, Rosa Miquel, Tommaso‐Maria Manzia, Juan G. Abraldes, Juan‐José Lozano, Marc Martínez‐Llordella, Marta López, Roberta Angelico, Felix Bohne, Pilar Sese, Frederic Daoud, Patrick Larcier, Dave L. Roelen, Frans Claas, Gavin Whitehouse, Jan Lerut, Jacques Pirenne, Antoni Rimola, Giuseppe Tisone, Alberto Sánchez‐Fueyo – 26 March 2013 – Lifelong immunosuppression increases morbidity and mortality in liver transplantation.
Ching‐Lung Lai, Man‐Fung Yuen – 26 March 2013
Petia Jeliazkova, Simone Jörs, Jens T. Siveke, Fabian Geisler – 23 March 2013
Matthias Evert, Frank Dombrowski, Biao Fan, Silvia Ribback, Xin Chen, Diego F. Calvisi – 23 March 2013
Laura Elisa Buitrago‐Molina, Silke Marhenke, Thomas Longerich, Amar Deep Sharma, Aristeidis E. Boukouris, Robert Geffers, Bruno Guigas, Michael P. Manns, Arndt Vogel – 23 March 2013 – Hepatocellular carcinoma (HCC) frequently arises in the context of chronic injury that promotes DNA damage and chromosomal aberrations. The cyclin‐dependent kinase inhibitor p21 is an important transcriptional target of several tumor suppressors, which promotes cell cycle arrest in response to many stimuli.
Cliff Rowe, Dave T. Gerrard, Roz Jenkins, Andrew Berry, Kesta Durkin, Lars Sundstrom, Chris E. Goldring, B. Kevin Park, Neil R. Kitteringham, Karen Piper Hanley, Neil A. Hanley – 23 March 2013 – Failure to predict hepatotoxic drugs in preclinical testing makes it imperative to develop better liver models with a stable phenotype in culture. Stem cell‐derived models offer promise, with differentiated hepatocyte‐like cells currently considered to be “fetal‐like” in their maturity.
Frederick J. Suchy – 23 March 2013
Jens U. Marquardt, Kerstin Fischer, Katharina Baus, Anubha Kashyap, Shengyun Ma, Markus Krupp, Matthias Linke, Andreas Teufel, Ulrich Zechner, Dennis Strand, Snorri S. Thorgeirsson, Peter R. Galle, Susanne Strand – 23 March 2013 – Sirtuin 6 (SIRT6) is a member of the sirtuin family of NAD+–dependent deacetylases. Genetic deletion of Sirt6 in mice results in a severe degenerative phenotype with impaired liver function and premature death. The role of SIRT6 in development and progression of hepatocellular carcinoma is currently unknown.
Matthew D. Hickey, David J. Quan, Peter V. Chin‐Hong, John P. Roberts – 22 March 2013 – Latent tuberculosis infection is an important problem for solid organ transplant recipients because of the frequency of its occurrence and its potential for reactivation. Because of the high mortality rate associated with active tuberculosis infections in transplant recipients, guidelines from the American Thoracic Society recommend treatment for latent tuberculosis in this population.